BMY:TSX, Bristol-Myers Squibb CDR (CAD Hedged)

BMY stock overview

Bristol-Myers Squibb CDR (CAD Hedged) (BMY:TSX) closed at $23.28 on November 12, 2026, up 1.04% on the day. The stock trades 1.3% below its 52-week high of $23.59 and 4.1% above its 52-week low of $22.36. Over the past year, it gained 2.3%. Bristol-Myers Squibb CDR (CAD Hedged) is part of the Health Care sector.

Key figures

Price
$23.28
Day change
+1.04%
Volume
5
Average volume
911
Market cap
181B+
52-week range
$22.36 – $23.59
50-day average
$22.94
200-day average
$22.94

Recent signals

BMY news

About Bristol-Myers Squibb CDR (CAD Hedged)

At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve.

Similar stocks

Find more stocks like BMY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.